Results

1–5 of 5 results for GALE

Clinical Utility of the Fellow Eye in Patients With Bilateral GA Due to AMD: Long-Term Data from thePegcetacoplan Clinical Program
Diana V Do, MD, FASRS
Annual Meeting Talks
2025
Early vs Delayed Pegcetacoplan Treatment for GA Secondary to AMD: 48-Month Results From OAKS, DERBY,and GALE Open-Label Extension
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2025
Effect of Pegcetacoplan on Photoreceptor and Retinal Pigment Epithelium Integrity in Geographic Atrophy in the Phase 3 Trials and GALE Extension Study
Ursula M. Schmidt-Erfurth, MD
Annual Meeting Talks
2023
Expert Panel: Pegcetacoplan Safety
Andre J. Witkin, MD
David A. Eichenbaum, MD, FASRS
Samuel Anthony Minaker, MD, MSc
Janani Singaravelu, MS, MD
Sunir J. Garg, MD, FACS, FASRS
Annual Meeting Talks
2024
Private Equity Panel
Richard Gale
Updates from the Field
2018